The University of Pittsburgh School of Medicine published a peer-reviewed paper this week in EBioMedicine suggesting that their COVID-19 vaccine candidate produces antibodies specific to SARS-CoV-2 (in mice), at quantities thought to be sufficient for neutralizing the virus. The vaccine would be delivered through a fingertip-sized patch. This is the 1st peer-reviewed study that describes a candidate vaccine for COVID-19.
The paper titled, “Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development” is in EBioMedicine.
The anti-vaccination crowd sure has been quite these days, don’t you think?